Skip to main content

Table 2 Participant’s demographic characteristics (n=23)

From: Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis

Category

Variable

Participants completed the study (20): n (%)

Participants lost to follow (3): n (%)

Gender

Female

14 (70%)

2 (66.67%)

Male

6 (30%)

1 (33.33%)

Age

18–24

-

-

25–34

-

-

35–44

6 (30%)

2 (66.67%)

45–54

6 (30%)

1 (33.33%)

55–64

6 (30%)

-

65–74

1 (5%)

-

75–84

-

-

85 or older

1 (5%)

-

Marital status

Single

2 (10%)

2 (66.67%)

Married

17 (85%)

1 (33.33%)

Widowed

-

-

Divorced

1 (5%)

-

Separated

-

-

MS type

RR MS

12 (60%)

2 (66.67%)

PP MS

5 (25%)

1 (33.33%)

SP MS

3 (15%)

-

PR MS

-

-

MS diagnosis in years

1–5

2 (10%)

-

6–10

8 (40%)

1 (33.33%)

11–15

3 (15%)

2 (66.67%)

16–20

3 (15%)

-

21–25

2 (10%)

-

26–30

1 (5%)

-

31–35

-

-

36–40

-

-

41–45

1 (5%)

-

LUTSs main

Urgency

16 (80%)

3 (100%)

Frequency

13 (65%)

2 (66.67%)

Nocturia

12 (60%)

1 (33.33%)

Urge incontinence

6 (30%)

1 (33.33%)

Terminal dribbles

4 (20%)

-

Hesitancy

5 (25%)

-

Feeling of incomplete bladder emptying

8 (40%)

1 (33.33%)

Urinary incontinence

5 (25%)

2 (66.67%)

Double void

4 (20%)

1 (33.33%)

LUTSs in years

1–5

6 (30%)

1 (33.33%)

6–10

9 (45%)

-

11–15

3 (15%)

2 (66.67%)

16–20

1 (5%)

-

21–25

1 (5%)

-

Previous TX

None

4 (20%)

1 (33.33%)

Pharmacologic

7 (35%)

1 (33.33%)

Non-pharmacologic:

  

Exercises

3 (15%)

1 (33.33%)

Nerve stimulation with another treatment (Exercise and/or Catheterization)

3 (15%)

-

Behavioural

3 (15%)

-

Current TX

None

6 (30%)

2 (66.67%)

Pharmacologic

9 (45%)

1 (33.33%)

Pharmacologic with Catheterization

2 (10%)

-

Non-pharmacologic:

Exercises

2 (10%)

-

Nerve stimulation

-

-

Behavioural

1 (5%)

-

Prophylactic

Yes

3 (15%)

-

No

17 (85%)

3 (100%)

Comorbidities

None

8 (40%)

1 (33.33 %)

Thyroid related issues

2 (10%)

1 (33.33%)

Hypertension

1 (5%)

1 (33.33%)

Reynolds syndrome

1 (5%)

 

Cancer

1 (5%)

-

Foot drop/mobility

2 (10%)

-

Migraine

1 (5%)

1 (33.33%)

hearing impairment

1 (5%)

-

Bowel related issues/duodenal ulcer

3 (15%)

-

PDDS-Mobility

(0) Normal

3 (15%)

-

(1) Mild disability

1 (5%)

 

(2) Moderate disability

3 (15%)

1 (33.33%)

(3) Gait disability

2 (10%)

 

(4) Early cane

3 (15%)

 

(5) Late cane

4 (20%)

1 (33.33%)

(6) Bilateral support

3 (15%)

 

(7) Wheelchair

1 (5%)

1 (33.33%)

(8) Bedridden

-

 
  1. MS multiple sclerosis, RR relapsing–remitting, SP secondary progressive, PP primary progressive, PR progressive relapsing, LUTSs lower urinary tract symptoms, PDDS Patient Determined Disease Step